Showing results (71-80 of 154) with videos related to
Sort By:
Pageof 16
Postgraduate Medical Journal|February 1, 1981
Poor rectal absorption of trimethoprim/sulphamethoxazole in treating Pneumocystis carinii pneumoniaR T Dorr, J R Powell, M Heick, et al.Biochemical Pharmacology|March 1, 1989
Role of glutathione and its associated enzymes in multidrug-resistant human myeloma cellsW T Bellamy, W S Dalton, P Meltzer, et al.Cancer Drug Delivery|January 1, 1986
Controlled studies of a new microprocessor-based portable infusion pumpR T Dorr, S E Salmon, M E Marsh, et al.Toxicology and Applied Pharmacology|September 30, 1987
Cisplatin nephrotoxicity: in vitro studies with precision-cut rabbit renal cortical slicesJ S Phelps, A J Gandolfi, K Brendel, et al.Journal of Medicinal Chemistry|October 1, 1991
Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agentsI Islam, E B Skibo, R T Dorr, et al.Cancer Letters|August 4, 2001
tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivoJ D Lambert, R O Meyers, B N Timmermann, et al.Journal of Medicinal Chemistry|August 1, 1988
Nucleotide derivatives of 2,7-diaminomitoseneB S Iyengar, R T Dorr, W A Remers, et al.Anti-Cancer Drugs|April 22, 1999
Intracellular localization of 6- and 7-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h]isoquino line-1,3-diones (azonafides) is not the limiting factor for their cytotoxicity: an in vitro confocal microscopy studyC A Mayr, S M Sami, W A Remers, et al.Cancer Letters|August 15, 2000
Dermal toxicity of topical (-)epigallocatechin-3-gallate in BALB/c and SKH1 miceS P Stratton, J L Bangert, D S Alberts, et al.Investigative Radiology|January 1, 1991
Cutaneous ulceration due to contrast extravasation. Experimental assessment of injury and potential antidotesE A Elam, R T Dorr, K E Lagel, et al.Pageof 16